(Q47764703)

5 February 2018

title

Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia (English)

1 reference

5 February 2018

1 reference

Pósán E

1

1 reference

5 February 2018

Ujj G

2

1 reference

5 February 2018

Kiss A

3

1 reference

5 February 2018

Telek B

4

1 reference

5 February 2018

Rák K

5

1 reference

5 February 2018

Udvardy M

6

1 reference

5 February 2018

publication date

1 April 1998

1 reference

5 February 2018

published in

Thrombosis Research

1 reference

5 February 2018

volume

90

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

51-56

1 reference

5 February 2018

Polycythemia vera. A clinical study of 141 patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

Profile of blood coagulation and fibrinolysis in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

The fibrinolytic system and proteins C and S in treated polycythaemia rubra vera

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

Tissue plasminogen activator levels in different types of polycythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

Plasminogen interacts with human platelets through two distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

Altered lysis resistance of platelet-rich clots in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

Fibrinolysis: Past and Present, a Reflection of Fifty Years

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

The physiological aspects of fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900005-X

7 January 2021

10.1016/S0049-3848(98)00005-X

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018